June 18, 2019 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10

Synergy and Cytation Readers Validated for Agilent MitoXpress and pH-Xtra Assays

June 18, 2019 BioTek is pleased to announce that its Synergy™ H1 and Synergy Neo2 Hybrid Multi-Mode Readers and its Cytation™ 1 and Cytation 5 Cell Imaging Multi-Mode Readers are validated for use with the MitoXpress and pH-Xtra Assays from Agilent Technologies. The assays may be used alone or combined to measure metabolism in live cells. Instructional Applications Bulletins are available for each multi-mode reader detailing the specific parameters... Read more

June 18, 2019 Clinical Research/Diagn. Product Launch

BD Unveils New Solution for High Throughput Molecular Diagnostic Testing

Automated BD COR™ System Achieves CE-IVD Status; Now Available in Europe Jun 18, 2019 FRANKLIN LAKES, NJ (June 18, 2019) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVDD certification of the BD COR™ System in Europe. The high throughput solution for infectious disease diagnostics sets a new standard... Read more

June 18, 2019 Clinical Research/Diagn. Life Science Tools PR/Corporate

Ontera Awarded ~$1M Contract from IARPA for Zika Genotyping Test

June 18, 2019 07:30 AM Eastern Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Ontera Inc., the leader in silicon-based nanopore diagnostics, announced today that the company has received a $982,593 contract from Intelligence Advanced Research Projects Activity (IARPA), part of the Office of the Director of National Intelligence that invests in research and innovative technologies to strengthen... Read more

June 17, 2019 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal

Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Ariosa Diagnostics, Inc. The Court found that Ariosa’s Harmony non-invasive prenatal test infringed EP 1 524 321 and that the... Read more

June 17, 2019 Clinical Research/Diagn. Licensing, IP, and Legal

FDA Grants Breakthrough Device Designation to Bio-Techne’s ExoDx™ Prostate Intelliscore™ (EPI) Test

JUNE 17, 2019 MINNEAPOLIS, June 17, 2019 /PRNewswire/ — Bio-Techne today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ExoDx Prostate IntelliScore (EPI) test, making it the first exosome-based liquid biopsy test to receive a Breakthrough Device Designation. This designation not only validates the clinical importance of... Read more

June 17, 2019 Cell Analysis Tools Clinical Research/Diagn. Product Launch

Fluidigm Scales Highly Multiplexed Cell Analysis with Introduction of Seven New Metal Markers

Powering industry-leading CyTOF technology to deliver new insights in translational and clinical research SOUTH SAN FRANCISCO, Calif., June 17, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will introduce seven new cadmium metal labeling kits for mass cytometry in Q3. Representing... Read more

June 17, 2019 Clinical Research/Diagn. PR/Corporate

BD Announces New Leadership for BD Biosciences

Jun 17, 2019 San Jose, Calif., June 17, 2019 – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the appointment of Puneet Sarin to worldwide president, BD Biosciences, effective today. In his new role, Puneet will be responsible for driving the global strategic, operational and commercial performance across BD Biosciences while advancing... Read more

June 13, 2019 Clinical Research/Diagn. Licensing, IP, and Legal

Bio-Techne Receives Approval to Offer the ExoDx™ Prostate IntelliScore™ (EPI) Test in New York State

JUNE 13, 2019 The EPI prostate biopsy rule-out test is now available in every state MINNEAPOLIS, June 13, 2019 /PRNewswire/ — Bio-Techne today announced that it has received a clinical laboratory permit from the New York State Department of Health to provide its ExoDx Prostate IntelliScore (EPI) test in New York, providing a valuable tool to help... Read more

June 12, 2019 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Saphetor SA and Swift Biosciences Announce Partnership to Standardize and Accelerate Data Interpretation for Targeted NGS Panels

Lausanne, June 12th, 2019 Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with Swift Biosciences Inc., a Michigan company based in Ann Arbor, USA, offering a set of differentiated next-generation sequencing (NGS) products and technologies for genomics, translational, and clinical research applications.... Read more

June 11, 2019 Acad, Gov/Utilities Atomic Spectroscopy Bio/Pharma/CRO Chromatography Clinical Research/Diagn. Lab Top-10

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., June 11, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration... Read more